A long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) for treatment of excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea

Authors
Category Primary study
JournalNeurology
Year 2019
This article has no abstract
Epistemonikos ID: 19938a93b2ee7947194d2f129f008b69449b1819
First added on: Feb 11, 2025